 T cells are major providers of proinflammatory cytokines. They are preprogrammed in the mouse thymus into distinct subsets producing either interleukin-17 (IL-17) or interferon- (IFN-), which segregate with CD27 expression. In the periphery, CD27
INTRODUCTION
The proinflammatory cytokines interferon- (IFN-) and interleukin-17A (IL-17) are critical mediators of T cell responses against intracellular bacteria and viruses, or extracellular bacteria and fungi, as illustrated by the high susceptibility of patients with mutations in the IFN- or IL-17 pathways to Mycobacterium tuberculosis or Candida albicans infections, respectively (1) . In addition to their protective roles in host defense, it has been shown that deregulated IFN- or/ and IL-17 production promotes chronic inflammation and autoimmunity. Thus, exacerbated IL-17 responses underlie inflammatory bowel disease, psoriasis, ankylosing spondylitis, and multiple sclerosis (1); and excessive IFN- is linked to type 1 diabetes and Crohn's disease (2) .
Although IFN- and IL-17 can derive from multiple cellular sources, there is often a major contribution from  T cells at early stages of immune responses (3) . Namely, IFN--producing  T cells play protective roles in viral, parasitic, and intracellular bacterial infections, such as Listeria monocytogenes (4, 5) . On the other hand, IL-17-producing  T cells promote neutrophil mobilization and host defense against Staphylococcus aureus, Escherichia coli, and C. albicans, among other infections (3) . IL-17-producing  T cells have gathered much recent attention because of their impact on animal models of inflammatory and autoimmune disorders such as psoriasis, colitis, arthritis, or multiple sclerosis (3) .
The prompt and abundant production of IFN- and IL-17 by  T cells is associated with their "developmental preprogramming" in the thymus (3, (6) (7) (8) (9) . Thus, we and others have shown that mouse  thymocytes can acquire the capacity to produce IFN- or IL-17, which associates with the expression of CD27 and CCR6, respectively (7, 10) . Our study on chromatin-based and transcriptional mechanisms governing  T cell differentiation revealed that CD27 +  (27 + ) T cells are committed to the expression of IFN- (but not of IL-17), whereas CD27
−  (27 − ) T cells exhibit a plastic behavior and can differentiate into cells that produce both IL-17 and IFN- (11) . Ifn and its transcriptional regulator Tbx21 displayed abundant active histone H3 marks (methylation of lysine K4 and acetylation) and were transcribed in both  T cell subsets. The coexpression of IFN- and IL-17 proteins by 27 − T cells was observed under strong inflammatory conditions seemingly driven by IL-1 and IL-23. The doubleproducing IL-17 + IFN- + 27 − T cells have been documented in animal models of cancer (11) , autoimmunity (12) , and infection (5) and also in HIV-1-infected patients (13) .
However, 27 − T cell plasticity seems limited when compared with that of CD4 + T helper 17 (T H 17) cells, which rapidly acquire the capacity to make IFN- when exposed to IL-12 or IL-23 in vitro (14) (15) (16) and have been found in colitis, Crohn's disease, arthritis, diabetes, multiple sclerosis, and experimental autoimmune encephalomyelitis (EAE) (14, 15) . Furthermore, analysis of an IL-17 fatemapping reporter mouse showed that, whereas CD4 + T cells that had expressed IL-17 promptly converted into IFN- producers in the spinal cord during EAE development, IL-17 +  T cells were much more resistant to the acquisition of IFN- production (14) . Because the Ifn locus displays active histone H3 marks and active transcription in 27 − T cells (11) , we hypothesized that microRNAs (miRNAs) might control IFN- expression at the post-transcriptional level in 27 − T cells. miRNAs drive their mRNA targets into the RNA-inducing silencing complex (RISC), in which Argonaute (AGO) proteins play a central role in preventing protein expression. Several miRNAs have been shown to affect the differentiation of cytokine-producing CD4 + T cell subsets [reviewed in 16) ]. To date, only two miRNAs have been characterized in  T cells, miR-133b and miR-206, which are co-regulated with IL-17 but have no impact on cytokine production (17) . Here, we have identified miR-146a as highly expressed in 27 − T cells compared with their 27 + T cell counterparts, and through 1 combined gain-of-function and loss-of-function approaches, we demonstrate that miR-146a inhibits IFN- production in  T cells and thus restricts the functional plasticity of 27 − T cells in vitro and in vivo.
RESULTS
miR-146a is highly expressed in 27 − T cells To address the role of miRNAs in the differentiation of proinflammatory  T cell subsets, we compared the ex vivo miRNA expression profile of highly purified CD27 + (27 + ) and CD27 − CCR6 + (27 − )  T cells isolated from pooled lymph nodes and spleen of naïve C57BL/6J mice. We identified 35 miRNAs differentially expressed (more than twofold) between 27 + and 27 − CCR6 + cells (Fig. 1A) . Only two related miRNAs, miR146a and miR-146b, were expressed at higher levels in 27 − CCR6
+ T cells when compared with 27 + cells. The differential expres sion of miR-146a (about fourfold) was fully validated by quantitative reverse trans cription polymerase chain reaction (RT-qPCR) analysis in peripheral 27 + and 27 − T cell samples (Fig. 1B) . In contrast to miR-146a, qPCR for miR-146b revealed very low levels of expression in all T cell subsets analyzed, including 27 − T cells (Fig. 1B and fig. S1A ).
The analysis of thymocyte subsets allowed us to establish that miR-146a is already differentially expressed during  T cell development, with a sharp increase as precursors mature into 27 − (but not 27 + ) thymocytes (Fig. 1C) . Furthermore, miR-146a expression was not modulated by exogenous T cell receptor (TCR) stimulation or inflammatory cytokines ( fig. S1B ). These data demonstrate that miR-146a expression is tightly regulated during  T cell differentiation, being confined to the subset that is preprogrammed in the thymus to produce IL-17 but no IFN- (7-9).
miR-146a inhibits IFN- production in  T cells
To gain insight into the function of miR146a in effector  T cell differentiation, we performed gain-of-function studies either by retroviral overexpression of a miR-146a construct or by electroporation of miR-146a mimics in  T cells. Both strategies require T cell activation and therefore act on fully differentiated  T cells obtained from spleen and lymph nodes. Moreover, TCR/IL-2 stimulation is known to enhance IFN- production in  T cells (18) . Retroviral transduction of the native stem loop of miR-146a in  T cells ( Fig. 2A) led to marked overexpression of mature miR-146a ( fig. S1C ), and this resulted in a significant reduction of the frequency of IFN- +  T cells compared with either an unrelated miR or a control vector alone (Fig. 2 , B and C), without affecting  T cell proliferation, as evaluated by Ki-67 staining (Fig. 2D) . These data were validated by an alternative gain-of-function approach based on the electroporation of synthetic miR-146a oligonucleotides (miR-146a mimics) in  T cells (Fig. 2E) , which significantly decreased the frequency of IFN- +  T cells when compared with control oligonucleotides (Fig. 2, F and G) . Overexpression of miR-146a did not affect T H 1 differentiation of CD4 + T cells (fig. S1, D and E) . These in vitro data suggest that miR-146a inhibits IFN- production in  T cells, leading us to hypothesize that isolated from pooled lymph nodes and spleen of C57BL/6 mice (more than twofold enrichment the high miR-146a levels in 27 − T cells in vivo (Fig. 1, B and C) restrict their capacity to express IFN-. miR-146a limits IFN- production and functional plasticity of 27 − T cells To explore the role of miR-146a in  T cell differentiation, we studied  T cells in miR-146a-deficient mice (19) . In vitro,  T cell proliferation upon TCR/CD28 stimulation was not affected by the absence of miR-146a ( fig. S2, A (Fig. 3B and fig. S4A ). The neonatal thymocytes are a prerequisite to generate IL-17-producing  T cells, because they are exclusively generated during fetal and perinatal life (21 producers. We found that 27 − T cells derived from miR-146a −/− were more prone to differentiate into double producers and expressed higher levels of IFN- than their WT counterparts (Fig. 3C ). We also confirmed that the absence of miR-146a did not affect IFN- production by 27 + T cells ( fig. S4B ). Together, these results indicate that miR-146a acts as a cell-intrinsic brake to IFN- production specifically in 27 − T cells, thereby limiting their functional plasticity. miR-146a targets Nod1 mRNA that is depleted in 27 − T cells To unravel the molecular mechanism(s) underlying miR-146a function, namely, the relevant mRNA target(s), we undertook an unbiased approach based on differential Argonaute 2 (Ago2) RNA immunoprecipitation followed by deep sequencing (Ago2 RIP-seq). Ago2 is a crucial protein that engages with both miRNA and its mRNA target(s) in the RISC. To overcome the problem of lack of commercially available high affinity antibodies against Ago2, we took advantage of a genetically modified mouse in which endogenous Ago2 is replaced with a N-terminal-tagged version of the protein (3×FLAG-6×HIS), thus allowing stringent purification (i.e., with low unspecific background) of the RNA molecules bound to Ago2 [upon ultraviolet (UV) cross-linking)], followed by RNA sequencing (RNA-seq) ( fig. S6 , A and C). To enrich for miR-146a targets, we transduced purified CD3 + T cells (we could not use  T cells because of insufficient cell numbers for this approach) with a miR-146a-expressing retrovirus (RV) (~12-fold overexpression of miR-146a, as shown in fig. S1C ). We thereby identified 225 putative mRNAs after differential Ago2 RIP-seq [data submitted to Gene Expression Omnibus (GEO)], from which 96 (42.7%) had a predicted miR-146a binding site in their 3′ untranslated region (3′UTR) ( fig. S6B ). This included two previously validated miR-146a targets, Zranb2 and Gtf2e2 [included in DIANATarBase v7.0 (22)]. Many of the other putative target transcripts had not been described in  T cells (table S1) , and these data thus constitute a useful resource for future studies. For this study, to narrow down the potential mRNA targets of miR-146a involved in the regulation of IFN- production in  T cells, we focused on genes with transcription factor or receptor activity ( Table 1 ) that had been associated with the IFN- pathway in other immune cells and, in particular, on two candidate genes, Atf2 (2.5-fold enriched in the RV-miR-146a sample), a transcription factor that binds to the IFN- promoter (23) , and Nod1, an intracellular pattern recognition receptor recently shown to enhance IFN- production in  T cells (24, 25) , which showed the highest fold difference (4.2-fold) among genes with receptor activity. Both putative targets have predicted miR-146a binding sites with canonical and noncanonical Watson-Crick base pairing (Fig. 5A) . To examine direct miR-146a targeting of Atf2 and Nod1, we designed reporter constructs in a pmirGLO Dual-luciferase miRNA target expression vector for the 3′UTRs of Atf2 and Nod1. We additionally included a negative control vector containing a 3′UTR without miR-146a binding sites and a positive control containing the 3′UTR of Notch1, a previously validated miR-146a target (26, 27) . We transiently transfected these constructs into human embryonic kidney (HEK) 293 T cells together with an expression plasmid for either miR-146a, an unrelated miRNA, or green fluorescent protein (GFP) control. Cotransfection of miR-146a (but not an unrelated miRNA) showed a significant repression of luciferase activity compared with GFP control for both mRNA targets (Fig. 5B) . Mutations in the miR-146a binding sites of both Atf2 and Nod1 led to significant recoveries of luciferase levels (Fig. 5, A and B) . We undertook various complementary mutational strategies to validate these findings, from mutating 3 to 11 individual base pairs (bp) to deleting the full binding region, always with consistent results (Fig. 5, A and B) . Together, these data demonstrate that miR-146a can target Atf2 and Nod1.
miR-146a restricts functional plasticity of 27 − T cells in Listeria infection
To investigate the potential impact of miR-146a on those mRNAs in  T cells, we analyzed their expression levels in 27 + and 27 − T cell subsets. Whereas Atf2 was similarly expressed in 27 + T cells (Fig. 5C ), Nod1 expression (Fig. 5C ) showed a notable negative association with miR-146a levels (Fig. 1, A (Fig. 6A) . Again, this was not due to proliferative defects (Fig. 6A) . The loss of Nod1 did not impair IL-17 production by 27 − T cells (Fig. 6A) . To functionally test the relevance of Nod1 as the target of miR-146a, we performed a genetic rescue experiment by crossing mR-146a −/− with Nod1 −/− mice and analyzing littermate controls with various genotypes. We found that reducing Nod1 (miR-146a −/− Nod1 +/− mice) prevented the accumulation of double producers among 27 − T cells observed in miR-146 −/− Nod1 +/+ mice (relative to miR-146 +/+ Nod1 +/+ controls) (Fig. 6B) , while not affecting 27 + T cell differentiation ( fig. S8 ). These data strongly suggest that Nod1 is a dominant target of miR-146a in regulating 27 − T cell plasticity. Last, to address the physiological relevance of Nod1 in vivo, we performed L. monocytogenes infection. Nod1 −/− mice were highly susceptible to Listeria infection, as illustrated by increased bacterial burden, severe weight loss, and death of Nod1 −/− (compared with both Nod1
+/+ and Nod1 +/− ) mice (Fig. 6C) . This was associated with strikingly reduced IL-17 + IFN- + 27 − T cells in Nod1 −/−  T cells (Fig. 6, D and E) . TCRd −/− mice were extremely susceptible to Listeria infection even more than Nod1 −/− mice (Fig. 6C) . Together, these data establish a critical function of Nod1 in promoting IFN- production and functional plasticity in 27 − T cells, which is inverse to the negative role of miR-146a in this process, and thus support the miR-146a/ Nod1 axis as a critical regulator of  T cell differentiation in vivo.
DISCUSSION
miRNAs are endowed with the capacity to regulate various molecular pathways of differentiation and functions in innate and adaptive immunity (29, 30) . In T cells, miRNA repertoires are known to change dramatically upon activation and across distinct functional T cell subsets (31, 32) . Building on our previous definition of proinflammatory  T cell subsets (7, 11) , we show here that miR146a is highly expressed selectively on 27 − T cells, where it targets Nod1 and thus limits IFN- production by this IL-17-biased subset.
The expression pattern of miR-146a was established during thymic  T cell development and was unaffected by exogenous TCR stimulation or inflammatory cytokine signals, further illustrating the importance of developmental preprogramming in  T cell biology (8, 9) . In the periphery, inflammatory signals are major drivers of functional plasticity of 27 − T cells, which manifests itself in the acquisition of IFN- , 7 days after infection with Listeria (n = 7 to 18 in three independent experiments). Each symbol in (A) and (D) represents an individual mouse. *P < 0.05 and **P < 0.01 (Mann-Whitney two-tailed test).
coproduction by previous IL-17 single producers. We found that the genetic loss of miR-146a led to the accumulation of multifunctional IL-17 + IFN- + double producers in vitro and in vivo, upon Listeria infection, where these cells had been associated with a protective memory response against the bacteria (5).
miR-146a has been previously associated with regulation of  T cell responses via dampening of nuclear factor B (NF-B) activation (33, 34) . In the absence of miR-146a, enhanced TCR-induced NF-B activation was linked to higher proliferation and increased production of effector cytokines including not only IFN- but also IL-17A and IL-2 by CD4 + and CD8 + T cells-that is, a general activation phenotype (33) . However, more recently, miR-146a was shown to inhibit the production of autocrine IL-6 and IL-21 in autoreactive transgenic CD4 + T cells, which rather reduced their T H 17 differentiation (35) . By contrast, our results show normal proliferation and IL-17 production by miR-146a −/−  T cells, thus highlighting the selective impact on IFN- coproduction by 27 − T cells, which may be linked to the high levels of expression of miR-146a in this subset. As a caveat of our study, we did not have the technical tools to specifically ablate miR-146a in  T cells, so we had to rely on full miR-146a "knockout" mice. No miRNA has yet been shown to play a role in T H 17/T H 1 plasticity. Looking globally at CD4 + T cell plasticity, miR-10a is thus far an isolated example of an miRNA implicated in limiting "lineage conversion"; being highly expressed in regulatory T cells, miR-10a prevents the acquisition of T H 17 and follicular helper T cell features (36) .
In contrast with the conventional targets (Traf6, Irak1, and Stat1, among others) of miR-146a in CD4 + T cells (33, 34) , the key mRNA target we identified for miR-146a in  T cells was Nod1. This target was identified by an unbiased Ago2-RIP approach in Ago2-tagged T cells after miR-146a overexpression. Although overexpression or deletion of a given miRNA gene regulates distinct sets of target genes (37), we favored an overexpression approach because, as each mRNA is targeted by multiple miRNAs, critical mRNA targets of miR-146a could be unaffected in RISCs of miR-146a −/− T cells. Instead, by providing an excess of miR-146a, we increased the possibility of dragging its mRNA targets into RISCs. Moreover, because miR-146a is a low expressed miRNA, selectively enriched in a minor (27 − ) T cell subset, using an overexpression system increases the signals attributable to this low abundant miRNA. The genome-wide Ago2 RIP-seq analysis allowed us to identify many potential previously unknown participants in the differentiation and activation of T cells. Here, we focused our analysis on Nod1, and our data suggest that miR-146a targets Nod1 not by canonical seed sequence-based pairing but by an alternative pathway already shown for other miRNAs [reviewed in (38) ], such as miR-155 that targets more than 40% of its mRNAs by noncanonical interactions (39) . This type of binding is very difficult to predict using standard strategies as those used by softwares like Targetscan (40) . Thus, in this analysis, we modified the standard parameters used by miRWalk (41) by allowing a minimum seed binding of five nucleotides and further refined the results by calculating the Gibb's function of the miRNA:mRNA hybrid. Because of 3′ compensatory binding, the results obtained for the selected miR-146a-5p target at the 3′UTR of Nod1 (G= −22.5 kcal/mol) are consistent with a stable miR-146:Nod1 hybrid.
Nod1 is a crucial pattern recognition receptor initially thought to be restricted to innate myeloid cells. However, Nod1 has been shown to be expressed by CD8 + T cells, at comparable levels to macrophages, and to functionally coactivate T cell proliferation and IFN- production (24) . We show here that  T cells, particularly the 27 + subset that makes IFN-, express Nod1. This is consistent with recent data showing that Nod1 ligation increases IFN- production by isolated CD8 + and CD4 + T cells in vitro, and Nod1-deficient T cells exhibited impaired IFN- production upon dextran sulfate sodium-induced acute inflammation and tumorigenesis in vivo (25) . The other prototypic Nod-like receptor, Nod2, was also suggested to play a T cellintrinsic role in IFN- production, which affected Toxoplasma gondii clearance (42) .
As confirmed by our data, Nod1 is a major determinant of resistance to L. monocytogenes infection (43) . The same applies to  T cells, but we could not directly link the two phenotypes because of lack of genetic tools to conditionally delete Nod1 specifically in  T cells. On the other hand, although in the infection setting Nod1 may be recognizing bacterial ligands such as peptidoglycan (44), the inability of Nod1-deficient 27 − T cells to differentiate into IFN- producers in vitro suggests an additional mechanism of Nod1 activation. As another limitation of our study, we have dissected neither this upstream mechanism nor the downstream regulators of cytokine production. Nod1 (and Nod2) are important mediators of endoplasmic reticulum (ER) stress-induced production of proinflammatory cytokines (45) . Future research should therefore address whether ER stress and the underlying unfolded protein response, known to be important drivers of inflammation and also to be induced upon T cell activation (46) , play a role in Nod1-dependent  T cell differentiation.
In sum, our data demonstrate that high levels of miR-146a in 27 − T cells suppress Nod1 expression, which is rescued upon ablation of miR-146a, thus promoting IFN- expression in thymically precommitted IL-17 producers. Multifunctional IL-17 + IFN- +  T cells have been associated with pathogenic  T cell responses in experimental models of (ovarian) cancer (11) and autoimmunity (EAE) (12) , and thus, the manipulation of miR-146a levels may have therapeutic potential.
MATERIALS AND METHODS

Mice
All mice used were adults 6 to 12 weeks of age. C57BL/6J and CD45.1 mice were from the Jackson Laboratory, and Rag2 −/− mice were from Taconic Biosciences. Il17a-GFP knock-in mice were from Biocytogen, LLC. miR-146a −/− mice have been described previously (19) . Nod1 −/− and Atf2 −/− mice were obtained from T. Mak (University Health Network, Toronto) and W. Breitwieser (Cancer Research UK Manchester Institute), respectively. The Ago2-tagged knock-in mice (EIF2c2-tag-KI) were generated by A.H.B.'s laboratory in conjunction with Biocytogen. A targeting vector was designed to insert a 147-bp N-terminal tag into the first exon of the Eif2c2 gene downstream of the ATG start site. The tag consists of 3×FLAG tag followed by a PreScission cleavage site and 6×HIS tag (sequence information available by request). A neomycin-selectable cassette was flanked by FLPe sites and inserted into the nonconserved region of intron 1 and targeted embryonic stem (ES) cells generated by homologous recombination. Selected ES cells were microinjected into C57BL/6 blastocysts and embryo transfer to pseudopregnant females. Chimeras were identified using standard procedures. Germline transmission was confirmed by Southern blotting and breeding program set up to establish the line. Both heterozygous and homozygous mice carrying the FLAG-HIS-tagged Ago2 are viable and fertile.
Mice were bred and maintained in the specific pathogen-free animal facilities of Instituto de Medicina Molecular (Lisbon, Portugal). All experiments involving animals were done in compliance with the relevant laws and institutional guidelines and were approved by the ethics committee of Instituto de Medicina Molecular.
Monoclonal antibodies
The following anti-mouse fluorescently labeled monoclonal antibodies (mAbs) were used (antigens and clones): TCR (GL3), V1 (2.11), V4 (UC3-10A6), CD3 (145.2C11), CD4 (GK1.5), CD8 (53-6.7), CD25 (PC61), CD27 (LG.7F9), CD44 (IM7), CD45.1 (A20), CD45.2 (104), Ki-67 (16A8), IFN- (XMG1.2), and IL-17A (TC11.18H10.1). Antibodies were purchased from BD Biosciences, eBiosciences, or BioLegend.
Cell preparation, flow cytometry, and cell sorting Cell suspensions were obtained from spleens, lymph nodes, or thymus. Erythrocytes were osmotically lysed in red blood cell lysis buffer (BioLegend). Cells were filtered through 70-m cell strainers (BD Biosciences). For cell surface staining, single-cell suspensions were incubated for 30 min with saturating concentrations of mAbs (see above). For intracellular cytokine staining, cells were stimulated with phorbol 12-myristate 13-acetate (50 ng/ml) and ionomycin (1 g/ml) in the presence of brefeldin A (10 g/ml) (all from SigmaAldrich) for 3 hours at 37°C. Cells were stained for the above identified cell surface markers, fixed 30 min at 4°C, permeabilized with the Foxp3/Transcription Factor Staining Buffer set (eBioscience) in the presence of anti-CD16/CD32 (eBioscience) for 15 min at 4°C, and lastly incubated for 1 hour at 4°C with the above identified antibodies in permeabilization buffer. Cells were sorted on FACSAria (BD Biosciences), and samples were acquired using FACSFortessa (BD Biosciences). Data were analyzed using FlowJo software (Tree Star).
miRNA array
All experiments were conducted at Exiqon Services. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile. Total RNA (250 ng) from sample and reference was labeled with Hy3 and Hy5 fluorescent label, respectively, using the miRCURY LNA miRNA Hi-Power Labelling Kit, Hy3/Hy5 (Exiqon, Denmark), following the procedure described by the manufacturer. The Hy3-labeled samples and a Hy5-labeled reference RNA sample were mixed pairwise and hybridized to the miRCURY LNA miRNA Array (sixth generation: hsa, mmu, and rno) (Exiqon, Denmark), which contains capture probes targeting all miRNAs for human, mouse, or rat registered in the miRBASE 16.0. The hybridization was performed according to the miRCURY LNA miRNA Array instruction manual using a Tecan HS 4800 hybridization station (Tecan, Austria). After hybridization, the microarray slides were scanned and stored in an ozone-free environment (ozone level below 2.0 parts per billion) to prevent potential bleaching of the fluorescent dyes. The miRCURY LNA array microarray slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies Inc.), and the image analysis was carried out using the ImaGene 9.0 software (BioDiscovery Inc.). The quantified signals were background-corrected (Normexp with an offset value of 10) and normalized using the Quantile normalization algorithm.
RNA isolation, complementary DNA production, and real-time PCR RNA was isolated from fluorescence-activated cell sorting (FACS)-sorted cell populations using a High Pure RNA Isolation kit (Roche) for total RNA and an miRNeasy Mini kit (Qiagen) or a High Pure miRNA Isolation kit (Roche) for small RNA. For total RNA, reverse transcription was performed with random oligonucleotides (Invitrogen) using Moloney murine leukemia virus reverse transcriptase (Promega). For miRNA, reverse transcription was performed with a Universal cDNA Synthesis kit II (Exiqon). For total RNA samples, relative quantification of specific complementary DNA (cDNA) species to endogenous references HPRT or Actinb was carried out using SYBR on a ViiA7 cycler (Applied Biosystems). Primers were either designed manually or by the Universal ProbeLibrary Assay Design Center (Roche), and their sequences were as follows: HPRT, GACCTCTCGAAGTGTTGGAT (forward) and GCTTTGTATTTGGCTTTTCC (reverse); Actb, CGT-GAAAAGATGACCCAGATCA (forward) and TGGTACGACCA-GAGGCATACAG (reverse); Nod1, CCTTCGTCCTGCATCACTTC (forward) and CTGGTTGACGCTGAGTCTGA (reverse); and Atf2, GAAGAGTCTCGCCCACAGTC (forward) and TGGGTCTGAG-GAGTTGTGTG (reverse). For miRNA samples, relative quantification of specific cDNA species to reference small RNA RNU5G or miR-423-3p was carried out using SYBR on a ViiA7 cycler (Applied Biosystems). The respective miRNA LNA primers were used (Exiqon).
Retroviral overexpression of miR-146a
The retroviral constructs encoding either mmu-miR-146a or an unrelated miRNA (mmu-miR-132) were generated by inserting the respective native pre-miRNA sequences flanked by about 200 bp into a modified pMig.IRES-GFP retroviral vector (Addgene #9044). miR-146a and miR-132 sequences were obtained by PCR from genomic DNA from C57BL/6J mice. The internal ribosomal entry site (IRES)-GFP sequence was removed and repIaced by PGK-GFP-WPRE sequence. The resulting vector encodes GFP under the control of the phosphoglycerate kinase (PGK) promoter and miR-146a or miR-132 under control of the retroviral long terminal repeat promoter. A Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element (WPRE) was inserted for increased viral titers. For retroviral transduction,  T cells and CD4 + T cells were sorted from lymph node and spleen of C57BL/6J mice and stimulated either with plate-bound anti-CD3 (145.2C11) plus anti-CD28 mAb (37.51) (both 2.5 g/ml) or platebound anti-CD3 (145.2C11) (5 g/ml) in the presence of soluble anti-CD28 (37.51) (2 g/ml) with IL-12 (5 ng/ml) and anti-IL-4 (11B11) (10 g/ml), respectively. The transduction was performed with polybrene (4 g/ml; Sigma-Aldrich), and medium was supplemented with IL-2 (5 ng/ml). Forty-eight hours after transduction, live cells using a LIVE/DEAD stain kit (Life Technologies), and GFP + cells were sorted and activated for intracellular staining.
 T cell electroporation  T cells were sorted from lymph node and spleen of C57BL/6J mice and stimulated with plate-bound anti-CD3 and anti-CD28 (both 2.5 g/ml).  T cells (2.5 × 10 4 ) were resuspended in T buffer and used per transfection with Neon electroporation transfection system (Invitrogen) with three pulses of 10 ms and 1550 V. miRIDIAN mimic of mouse mmu-miR-146a-5p (Dharmacon) and miRIDIAN mimic negative control #1 (Dharmacon) with an RNA concentration of 500 nM per electroporation were used. After electroporation, cells were cultured in media supplemented with IL-2 (5 ng/ml) and 48 hours later activated for intracellular cytokine staining.
In vitro  T cell stimulation and CD4
+ T H cell polarization 27 + and 27 − T cells were FACS-sorted and subjected to various stimulation conditions overnight or for 24 to 72 hours. Cells were incubated on plate-bound anti-CD3 (145.2C11) plus anti-CD28 mAb (37.51) (both at 2.5 g/ml) supplemented with IL-12 (10 ng/ml) or, alternatively, in the presence of murine IL-1 plus IL-23 (both 50 ng/ml) or IL-12 (10 ng/ml). For T H 1 cell culture conditions, FACSsorted CD4 + T cells were incubated with plate-bound anti-CD3 (145.2C11) and soluble anti-CD28 mAb (37.51) (both at 2 g/ml) in the presence of IL-12 (5 ng/ml) and neutralizing anti-IL-4 mAb (11B11) (5 g/ml) for 5 days. All cytokines were from PeproTech, except TGF-b and IL-23, which were from R&D systems.
L. monocytogenes infection and bacterial quantification
We used L. monocytogenes strain EGDe, carrying a recombinant InlA with a mutation in S192N and Y369S, as previously described (5) . Briefly, all mice were deprived of food overnight before infection, housed individually, and given a ~0.5-cm 3 piece of mashed food inoculated with 2 × 10 9 colony-forming units (CFUs) of L. monocytogenes in phosphate-buffered saline. CFUs were calculated from single-cell suspensions of spleens plated in serial dilutions on Brain Heart Infusion agar plates. Individual colonies were counted after 30 hours of incubation at 37°C.
Neonatal thymocytes and BM chimeras
Chimeras were generated as previously described (20) . Briefly, Rag2 −/− mice were lethally irradiated (9.5 gray) and injected 6 hours after with a 1:1 mix of neonatal thymocytes (5 × 10 6 to 10 × 10 6 thymocytes per host) isolated from WT (CD45.1/CD45.2) and miR-146a −/− (CD45.2) donors within 48 hours after birth. After 24 hours, the host received a 1:1 mix of 5 × 10 6 to 10 × 10 6 BM cells isolated from WT (CD45.1/ CD45.2) and miR-146a −/− (CD45.2) donors. Chimeras were kept on antibiotic-containing water (2% Bactrim; Roche) for the first 4 weeks after irradiation. The hematopoietic compartment was allowed to reconstitute for 8 weeks before the animals were used for experiments.
Differential Argonaute 2 RNA immunoprecipitation followed by deep sequencing CD3 + T cells were FACS-sorted from pooled spleens of Ago2-tagged (3×FLAG-6×HIS tag) mice and stimulated with plate-bound anti-CD3 (145.2C11) plus anti-CD28 mAb (37.51) (both 2.5 g/ml) and transduced either with RV-miR-146a vector or RV-control vector. Twenty-four hours after transduction, GFP + live cells [using a live/ dead stain kit (Life Technologies)] were FACS-sorted. Cells (7 × 10 5 to 2 × 10 6 ) were UV-cross-linked in Stratalinker 2400 (400 mJ cm −2 ) and lysed. AGO-interacting RNA was immunoprecipitated using antiFlag (M2) magnetic beads (Sigma-Aldrich). Following, Ago2-bound RNA was partially digested using RNase IT (Agilent Technologies) and, in a second step, purified using the HIS-tag and Ni-nitrilotriacetic acid beads (Qiagen) under high stringent denaturing wash conditions. After proteinase K treatment, RNA was isolated using phenolchloroform isoamyl extraction (detailed protocol available upon request). The quality of the RNA was verified by an Agilent 2100 Bioanalyzer profile, and libraries were prepared using a Clontech SMARTer Stranded RNA-Seq Kit, starting with 8 l of the immunoprecipitated RNA. The manufacturer's solid phase reversible immobilization (SPRI) protocol was followed, using 4 min for RNA fragmentation, double bead cleanup after reverse transcription, and 20 PCR cycles for amplification. The resulting libraries were sequenced using Illumina HiSeq 2000 instrument with 50-bp single-read sequencing mode.
Ago2 RIP-seq data analysis
To assess overall RNA-seq data quality, sequence length distribution and the base calling accuracy as indicated by the Phred quality score (Q score) were calculated with high-throughput sequence data quality control software FastQC (version 0.10.1; Babraham Bioinformatics, UK). Adaptor sequences were trimmed using FASTX-toolkit. Sequence reads were mapped to the mouse reference genome (GRCm38) using Bowtie2 software (47) . Aligned reads were thereafter sorted and indexed by SAMtools (48) , Cuffdiff software, a part of the Cufflinks suite (49) , was used to detect significant changes in mRNA enrichment between the experimental groups. Genes with a P value, for statistical significance, and q value, to detect the false discovery rate, of <0.05 were considered differentially enriched in Ago2-RIP experiments. Predicted miRNA targets for mmu-miR-146a were determined by miRWalk2 algorithm (41) .
Dual luciferase reporter assay
The 3′UTR of Nod1, Atf2, Notch1 (positive control), and PTPBP2 (negative control) were cloned into pmirGLO vector (Promega) from genomic DNA. Primers are available upon request. Mutations in the predicted target sequences of the 3′UTRs were introduced by gene synthesis (GeneCust Europe). The luciferase reporter vectors carrying either the WT or mutant 3′UTR-sequence were transfected with the miR-146a expression vector, an unrelated miRNA (miR-132), or a control vector into HEK293 T cells (ATCC CRL-3216) using Lipofectamine 2000 (Thermo Fisher Scientific) or electroporated into PEER T-ALL cells [DSMZ (German Collection of Microorganisms and Cell Cultures), Braunschweig, Germany], following the manufacturer's protocol. After 48 hours, firefly and Renilla luciferase activity were measured by using the Dual-Glo Luciferase Assay System (Promega). Renilla luciferase activity served as the internal control, and results were expressed as relative luciferase activity.
Carboxyfluorescein diacetate succinimidyl ester staining
For analysis of proliferation, FACS-sorted CD4 + and  T cells were stained by incubation for 5 min at 37°C with 5 mM CFSE (carboxyfluorescein diacetate succinimidyl ester; Molecular Probes). Reactions were quenched by washing with ice-cold RPMI medium supplemented with 10% (v/v) fetal calf serum. CFSE-labeled cells were stimulated with plate-bound anti-CD3 (145.2C11) plus anti-CD28 mAb (37.51) (both 2.5 g/ml). After 4 days, the proliferation was assessed by flow cytometry.
Bromo-deoxyuridine incorporation
Mice were given intraperitoneal injections of 1.5 mg of bromodeoxyuridine (BrdU) on the day of L. monocytogenes infection, and BrdU at a concentration of 0.8 mg/ml was supplemented in the drinking water during the course of infection. Incorporation of BrdU was determined by a BrdU Flow kit (BD Pharmingen) following manufacturer's protocol.
Statistical analysis
The statistical significance of differences between populations was assessed using a two-tailed nonparametric Mann-Whitney test or Student's t test. P < 0.05 was considered significant and is indicated on the figures.
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